PTC Therapeutics, Inc. Debt/Assets

Debt/Assets of PTCT for past 10 years: annual, quarterly and twelve month trailing (TTM) including Debt/Assets growth rates and interactive chart.


Highlights and Quick Summary

  • Debt/Assets for the quarter ending June 30, 2022 was 33.2% (a 12.31% increase compared to previous quarter)
  • Year-over-year quarterly Debt/Assets decreased by -47.07%
  • Annual Debt/Assets for 2021 was 27.66% (a 45.04% increase from previous year)
  • Annual Debt/Assets for 2020 was 19.07% (a -5.59% decrease from previous year)
  • Annual Debt/Assets for 2019 was 20.2% (a 47.77% increase from previous year)
Visit stockrow.com/PTCT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Debt/Assets of PTC Therapeutics, Inc.

Most recent Debt/Assetsof PTCT including historical data for past 10 years.

Interactive Chart of Debt/Assets of PTC Therapeutics, Inc.

PTC Therapeutics, Inc. Debt/Assets for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 33.2% 29.56%
2021 27.66% 62.73% 60.51% 54.22% 27.66%
2020 45.83% 45.38% 22.85% 20.35% 19.07%
2019 19.33% 19.08% 12.05% 12.08% 20.2%
2018 13.67% 14.67% 29.09% 38.71% 13.67%
2017 37.02% 38.91% 36.87% 40.18% 36.99%
2016 36.46% 33.6% 31.07% 27.85% 36.46%
2015 25.14% 23.53% 0.0% 0.0% 25.14%
2014 0.0% 0.0% 0.0% 0.0% 0.0%
2013 0.03% 0.05% 1.57% 6.4% 0.03%
2012 37.35% 0.0% 0.0% 0.0% 37.35%
2011 26.44% 26.48%

Business Profile of PTC Therapeutics, Inc.

Sector: Healthcare
Industry: Biotechnology